Since anti-cancer activities of bisphosphonates can be augmented by cytotoxic agents [9–12] and we have observed the combination effect of Zol and docetaxel (data not shown), we examined whether docetaxel can also enhance the effect of GGTI. This evidence concerns the gene PGGT1B and cancer.